Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 14,794 | 12,584 | 10,705 | 10,988 | 8,089 |
| Operating Income | -14,794 | -12,584 | -10,705 | -10,988 | -8,089 |
| Other Income | 741 | 851 | 851 | 374 | -3,292 |
| Pre-tax Income | -14,053 | -11,733 | -9,854 | -10,614 | -11,381 |
| Net Income Continuous | -14,053 | -11,733 | -9,854 | -10,614 | -11,381 |
| Net Income | $-14,053 | $-11,733 | $-9,854 | $-10,614 | $-11,381 |
| EPS Basic Total Ops | -0.39 | -0.32 | 1.65 | -0.30 | -1.40 |
| EPS Basic Continuous Ops | -0.39 | -0.32 | 1.81 | -0.30 | -1.40 |
| EPS Diluted Total Ops | -0.39 | -0.32 | 1.65 | -0.30 | -1.40 |
| EPS Diluted Continuous Ops | -0.39 | -0.32 | 1.81 | -0.30 | -1.40 |
| EPS Diluted Before Non-Recurring Items | -0.39 | -0.32 | N/A | N/A | N/A |
| EBITDA(a) | $-14,776 | $-12,569 | $-9,726 | $-11,935 | $-8,075 |